DURAVYU has established safety and efficacy data from both Phase 1 and 2 trials in wet AMD and DME that demonstrate stability in vision and anatomical control with a single dose of DURAVYU. No ...

Biogen Inc. (Nasdaq: BIIB) today announced the successful completion of the acquisition of Apellis Pharmaceuticals, Inc.

A new study published in the Journal of the American Medical Association found that administration of anti–vascular ...

Healthy Vision Month in May is a great time for Texans to focus on protecting their vision health and preventing eye disease. To keep eyes healthy, schedule regular eye exams to check for common ...

Many common conditions linked to aging develop without symptoms for years. Learn which five pose the biggest risks and the ...

Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a pioneering biotechnology leader in gene therapies for blindness diseases, today announced the closing of $130.0 million aggregate principal ...

When the uncle of Dr. David Rhew’s co-worker visited the emergency department with severe abdominal pain, he received a scan ...

Emerging opportunities in the C5 inhibitor market include advances in biosuperiors and biosimilars, targeting a range of C5-mediated diseases such as PNH and aHUS. Innovations focus on enhancing ...

The Labour government is trying to reduce road deaths through its Road Safety Strategy, with cognitive and eyesight testing ...

Six potential changes are being considered for drivers aged 70 and over as part of a Labour Party government consultation.

An expert MD reveals clear insights into cataract surgery, spotlighting the breakthroughs in treatment: "We live in a time of miracle and wonder." The post “What I Wish I’d Known About Cataract ...

More than 750,000 motorists across the UK have a medical condition that can affect their driving ability, according to recent ...